[HIV protease inhibitors. A new drug class in antiretroviral therapy].
Mauss
S
S
Klinik für Gastroenterologie, Hepatologie und Infektiologie, Universität Düsseldorf.
Seidlitz
B
B
Jablonowski
H
H
Häussinger
D
D
D019380:Anti-HIV Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D006801:Humans; D019469:Indinavir / Q000627:therapeutic use; D009705:Nucleosides / Q000627:therapeutic use; D019438:Ritonavir / Q000627:therapeutic use; D019258:Saquinavir / Q000627:therapeutic use
D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors; D009705:Nucleosides; D019469:Indinavir; D019258:Saquinavir; D019438:Ritonavir
HIV-Proteaseinhibitoren. Eine neue Substanzklasse in der antiretroviralen Therapie.